Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
Researchers Find Genetic Targets for Strabismus Treatment
Researchers at Boston Children’s Hospital have made a significant advancement in understanding the genetic components of strabismus, a common eye condition that causes misalignment of the eyes, specifically esotropia (eyes turning inward) and exotropia (eyes turning outward). They discovered chromosomal…
Ocular Therapeutix Reports Promising Axpaxli Results in DR Study
Ocular Therapeutix announced positive topline results from its phase 1 HELIOS study, which evaluated the safety, tolerability, and efficacy of Axpaxli versus a sham control in patients with moderately severe to severe nonproliferative diabetic retinopathy (NPDR) without diabetic macular edema…
Eye Health Initiative Overcomes Access Barriers in Malawi
In an inspiring leap towards health equity, a new eye health project in Malawi has successfully brought essential services to the grassroots level. This initiative, supported by Sightsavers, has notably reached over 122,000 individuals in rural and economically disadvantaged areas…
Caplin Granted USFDA Approval for Key Ophthalmic Solution
Caplin Steriles Limited (Caplin), a subsidiary of Caplin Point Laboratories Limited, has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ketorolac Tromethamine Ophthalmic Solution 0.5%. This product is…
Pravin U. Dugel Becomes President & CEO at Ocular Therapeutix
Ocular Therapeutix announced a significant shift in its leadership structure, as Executive Chairman, Pravin U. Dugel, MD, will now also take on the roles of President and Chief Executive Officer. Dr. Dugel will continue his duties as a director and…
Kiora Receives Key Grant for Clinical Trials in Vision Impairment
Kiora Pharmaceuticals announced that it has secured a grant from the Choroideremia Research Foundation (CRF) to support novel clinical trial endpoints for inherited retinal diseases (IRDs). The grant will fund the validation of the Multiluminence Orientation & Mobility (MLOM™) suite…
DOJ Files Lawsuit Against Regeneron Over Eylea Pricing
The U.S. Department of Justice (DOJ) has initiated a lawsuit against Regeneron Pharmaceuticals under the False Claims Act (FCA), accusing the biotechnology company of fraudulently inflating Medicare reimbursement rates. According to the DOJ, Regeneron submitted false average sales price reports…
Oasis Medical Launches New Tapered Plug for DED Treatment
Oasis Medical has recently unveiled its latest product, the SOFT PLUG Extended Duration 180-T Tapered Plug, which is engineered to aid individuals suffering from dry eye syndrome and related ocular surface diseases. The new tapered plugs are designed for ease…
Haag-Streit Unveils Retinopathy of Prematurity Simulator
In a significant development aimed at enhancing the training of ophthalmologists, Haag-Streit has unveiled the Eyesi Indirect Ophthalmoscope ROP Simulator. This novel simulator is specifically designed for the training of retinal examinations on preterm infants and the classification of retinopathy…
Lenz Therapeutics Reports Study Success for Presbyopia
Lenz Therapeutics announced positive topline results from its Phase 3 CLARITY study, evaluating two investigational formulations, LNZ100 and LNZ101, aimed at treating presbyopia. The study’s findings showcase the effectiveness and safety of these formulations, particularly highlighting LNZ100 (1.75% aceclidine) for…